
Please try another search
Veru, Inc. (NASDAQ:VERU) has filed $200,000,000 mixed shelf of: Common Stock Debt Securities Preferred Stock Warrants Purchase Contracts Rights Units
Veru, Inc. (NASDAQ:VERU) disclosed: On March 14, 2023, at the Oppenheimer 33rd Annual Healthcare Conference, Dr. Mitchell Steiner, M.D., Chairman, President and Chief Executive Officer of Veru Inc....
After-Hours Stock Movers: Veru Inc. (NASDAQ:VERU) 40% LOWER; announced that the U.S. Food and Drug Administration (FDA) has declined to grant at this time the company's request for Emergency Use...
Veru Inc. (NASDAQ:VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral ARDS-related diseases and for oncology, today announced that the U.S. Food and...
Veru, Inc. (VERU) reported Q1 EPS of ($0.46), $0.11 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $2.51 million versus the consensus estimate of $7.57 million.
Investing.com - Veru (NASDAQ: VERU) reported first quarter EPS of $-0.460, $0.11 worse than the analyst estimate of $-0.350. Revenue for the quarter came in at $2.51M versus the consensus estimate of...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review